Clostridium Difficile Infection Complicated By Toxic Megacolon In Immunocompetent Patient
Author:
Draganescu Miruna1, Baroiu Liliana1, Iancu Alina1, Arbune Manuela1, Dumitru Irina Magdalena2, Rugina S.34
Affiliation:
1. Medicine and Pharmacy Research Center, “Dunărea de Jos” University of Galati, Faculty of Medicine, Romania 2. University “Ovidius” of Constanta, Faculty of Medicine, Romania 3. University “Ovidius” of Constanta, Faculty of Medicine Romania 4. Academy of Romanian Scientists, Romania
Abstract
Abstract
Toxic megacolon can be a form of severe clinical course of the infection with Clostridium difficile (ICD), life-threatening, requiring a particular course of treatment. Infection with Clostridium difficile in the Galati Infectious Disease Hospital presents rising number of cases, namely 172 cases in 2014, 271 cases in 2015 and 301 cases in 2016 with clinical evolutions with different severity degrees, including toxic megacolon and death. Among 744 patients with ICD in our clinic, since 1st January 2014 to 31 December 2016. The frequency of toxic megacolon (TM) was 0,537%, so: 3 toxic megacolon cases with favorable evolution with treatment with vancomycin and metronidazole and just one case whose evolution was aggravated under this therapy and evolved favorably under treatment with tigecycline. The work presents this last case of ICD occurred in a 69 years old, immunocompetent man with unknown concomitant chronic diseases which undergoes surgery for bilateral inguinal hernia and receives antibiotherapy with cephalosporin IIIrd generation during surgery and after 7 days develops medium degree ICD with score Atlas 3 and receives therapy with oral vancomycin. He presents clinical aggravation during this therapy with the occurrence of colon dilatation, ascites and right pleurisy at ultrasound and therapy associated with metronidazole is decided. Clinical aggravation continues in this combined therapy with defining the clinical, colonoscopy and tomography criteria for TM and is decided surgical monitoring and replacing antibiotherapy with tigecycline. Evolution is favorable with tigecycline without surgical intervention.
Publisher
Walter de Gruyter GmbH
Subject
General Biochemistry, Genetics and Molecular Biology
Reference31 articles.
1. 1. Cohen, S., Gerding, D., Johnson, S, Kelly, C., Loo, V., McDonald, C., Pepin, J. & Wilcox, M. (2010). Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA), Infection Control & Hospital Epidemiology, Vol. 31, Issue 5, 431-455, DOI: http://dx.doi.org/10.1086/651706. 2. 2. McDonald, L.C., Owings, M. & Jernigan, D.B. (2006). Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003, Emerging Infectious Diseases Journal, Vol. 12, 409-415. 3. 3. Redelings, M.D., Sorvillo, F. & Mascola, L. (2007). Increase in Clostridium difficile-related mortality rates, United States, 1999-2004, Emerging Infectious Diseases Journal, Vol. 13, 1417-1419. 4. 4. Burckhardt, F., Friedrich, A., Beier, D. & Eckmanns, T. (2008). Clostridium difficile surveillance trends, Saxony, Germany, Emerging Infectious Diseases Journal, Vol. 14, pp. 691-692. 5. 5. Gravel, D., Miller, M., Simor, A., Taylor, G., Gardam, M., McGeer, A., Hutchinson, J., Moore, D., Kelly, S., Boyd, D. & Mulvey, M. (2009). Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin Infect Dis. 48(5), 568-576. doi: 10.1086/596703
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|